Cargando…
Cathepsin L-mediated resistance of paclitaxel and cisplatin is mediated by distinct regulatory mechanisms
BACKGROUND: Cathepsin L (CTSL) is a cysteine protease known to have important roles in regulating cancer cellular resistance to chemotherapy. However mechanism underlying which regulates CTSL-mediated drug resistance remain largely unknown. METHODS: We used NSCLC cell lines: A549, A549/TAX (paclitax...
Autores principales: | Zhao, Yifan, Shen, Xiao, Zhu, Ying, Wang, Anqi, Xiong, Yajie, Wang, Long, Fei, Yao, Wang, Yan, Wang, Wenjuan, Lin, Fang, Liang, Zhongqin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6670178/ https://www.ncbi.nlm.nih.gov/pubmed/31370861 http://dx.doi.org/10.1186/s13046-019-1299-4 |
Ejemplares similares
-
Cathepsin L activated by mutant p53 and Egr-1 promotes ionizing radiation-induced EMT in human NSCLC
por: Wang, Wenjuan, et al.
Publicado: (2019) -
CD200-CD200R affects cisplatin and paclitaxel sensitivity by regulating cathepsin K-mediated p65 NF-κB signaling in cervical cancer
por: Mou, Junjun, et al.
Publicado: (2023) -
Hederagenin potentiated cisplatin- and paclitaxel-mediated cytotoxicity by impairing autophagy in lung cancer cells
por: Wang, Kun, et al.
Publicado: (2020) -
Regulatory role of cathepsin L in induction of nuclear laminopathy in Alzheimer’s disease
por: Islam, Md Imamul, et al.
Publicado: (2021) -
Cathepsin L promotes chemresistance to neuroblastoma by modulating serglycin
por: Du, Xiaohuan, et al.
Publicado: (2022)